Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ISPR
ISPR logo

ISPR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Ispire Technology Inc (ISPR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.710
1 Day change
-8.56%
52 Week Range
4.700
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Ispire Technology Inc (ISPR) is not a strong buy for a beginner, long-term investor at this time. The lack of positive catalysts, weak financial performance, and absence of significant trading signals suggest holding off on investment until better opportunities arise.

Technical Analysis

The MACD is positive and expanding, indicating a mild bullish trend. RSI is neutral at 57.365, and moving averages are converging, showing no clear momentum. Key support is at 1.697, and resistance is at 1.942. The stock has a 70% chance to decrease by -1.17% in the next day and a modest 2.31% increase in the next month.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options data indicates very low trading activity, with a high call open interest and negligible put activity. Implied volatility is high at 106.83%, but IV rank is low at 18.43%, suggesting limited interest in the stock.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
12
Buy
1

Positive Catalysts

  • No significant positive catalysts identified.

Neutral/Negative Catalysts

  • Revenue dropped by -51.50% YoY, net income declined by -17.45% YoY, and EPS fell by -14.29% YoY in the latest quarter (2026/Q2). Gross margin also decreased by -7.20%. No recent news or significant insider/hedge fund activity to support a positive outlook.

Financial Performance

The company's financial performance in 2026/Q2 shows significant declines across key metrics: revenue (-51.50%), net income (-17.45%), EPS (-14.29%), and gross margin (-7.20%). These trends indicate weak growth and profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data available for ISPR.

Wall Street analysts forecast ISPR stock price to rise
1 Analyst Rating
Wall Street analysts forecast ISPR stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.870
sliders
Low
6.5
Averages
6.5
High
6.5
Current: 1.870
sliders
Low
6.5
Averages
6.5
High
6.5
Roth Capital
Buy
downgrade
$9
AI Analysis
2025-05-15
Reason
Roth Capital
Price Target
$9
AI Analysis
2025-05-15
downgrade
Buy
Reason
Roth Capital lowered the firm's price target on Ispire Technology to $7.50 from $9 and keeps a Buy rating on the shares. The company's Q2 results were "tempered" as shipment timing on its U.K. supply agreement is being pushed into fiscal Q4 and given that Chinese New Year seasonality and tariffs are also impacting order timing, the analyst tells investors in a research note. An FDA decision in the coming months should provide greater future visibility around licensing opportunities, the firm adds.

People Also Watch